Cost-Effectiveness Analysis of Transplant-Ineligible Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treatment Options: Experience of the Efficiency Frontier Approach
Source : https://pubmed.ncbi.nlm.nih.gov/37644352/
Using the EF approach, the currently most cost-effective interventions (based on cost-effectiveness ratios) in the indication of R/R DLBCL were identified to guide international reimbursement decisions.
Using the EF approach, the currently most cost-effective interventions (based on cost-effectiveness ratios) in the indication of R/R DLBCL were identified to guide international reimbursement decisions.
Composite Lymphoma With Follicular Lymphoma Transformation to Clonally Related Epstein-Barr Virus (EBV) Positive Diffuse Large B-Cell Lymphoma and EBV-Positive Classic Hodgkin Lymphoma
Source : https://www.hindawi.com/journals/crihem/2023/8833273/
While the Epstein–Barr virus (EBV) is known to drive de novo lymphomagenesis, it may rarely contribute to transformation of indolent lymphoma as well. Some EBV-related lymphomas represent a diagnostic challenge...
Eradication of DLBCL and FL components but persistence and subsequent overt relapse as cHL in this case raises the question as to whether the identification of composite lymphomas with both DLBCL and cHL should alter initial therapy.
Correlation Between Red Blood Cell Distribution Width/Platelet Count and Prognosis of Newly Diagnosed Diffuse Large B-Cell Lymphoma
Source : https://www.bloodresearch.or.kr/journal/view.html?doi=10.5045/br.2023.2023156
Xiaobo Liu, Yanliang Bai, Ying Liu, Weiya Li, Yabin Cui, Jinhui Xu, Xingjun Xiao, XiaoNa Niu, Kai Sun. Blood Res -0001;0:. https://doi.org/10.5045/br.2023.2023156
Dissemination Feature Based on PET/CT Is a Risk Factor for Diffuse Large B Cell Lymphoma Patients Outcome
Source : https://bmccancer.biomedcentral.com/articles/10.1186/s12885-023-11333-z
18F-FDG PET/CT provides precise information about dissemination of lymphoma lesions. Dmax, defined as distance between the two lesions that were farthest apart by PET/CT, was found to be a promising...
Although subsequent evidence did not identify metabolic tumor volume (MBV) as an independent prognostic factor for PFS, it still revealed MBV as an independent predictor of OS in patients with DLBCL.
Clot Waveform Analysis for Hemostatic Abnormalities
Source : https://www.annlabmed.org/journal/view.html?doi=10.3343/alm.2023.43.6.531
Hideo Wada, M.D., Ph.D., Katsuya Shiraki, M.D., Ph.D., Takeshi Matsumoto, M.D. Ph.D., Hideto Shimpo, M.D., Ph.D., and Motomu Shimaoka, M.D., Ph.D.. Ann Lab Med 2023;43:531-8. https://doi.org/10.3343/alm.2023.43.6.531
CWA can show abnormal waveforms, peak times, and peak heights and increases the ability to diagnose various hemostatic abnormalities. Modified CWA improves the routine clotting time assay to allow the examination of complex hemostatic abnormalities.